A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial

Raj Satkunasivam, Kelvin Lim, Bin S. Teh, Jonathan Guzman, Jun Zhang, Andrew Farach, Shu Hsia Chen, Christopher J.D. Wallis, Eleni Efstathiou, Nestor F. Esnaola, Guru P. Sonpavde

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial'. Together they form a unique fingerprint.

Medicine & Life Sciences